Sigyn Therapeutics, Inc. (OTC - SIGY) could change the way we treat sepsis, the #1 cause of death in hospitals, as well as COVID-19.

Restaurant.com Parent RDE Inc. (OTCQB: RSTN) went from $2 to $4.48 in just 2 weeks for us before trending back. See why we think it can double again.

Mitesco, Inc.'s (OTCQB - MITI) flagship subsidiary is launching the first location---today---of a novel new clinic that should generate more recurring sales and profit than its peers.

As an early-stage biotech, each milestone event typically leads to higher prices. QSAM Biosciences, Inc. (OTCQB - QSAM) just raised $2.5M and is soon to commence a Phase I trial.

Home Bistro, Inc. (OTC - HBIS) is a pure play gourmet meal delivery firm enjoying outsized growth and could emerge as one of the stars of the multi-billion-dollar industry, aided by its relationship with Iron Chef Cat Cora.

A big winner that is up 360%+ since our October 2020 initiation, there are a number of reasons why we are raising our target on iQSTEL, Inc. (OTC - IQST) today, with more increases in the offing.

Significant news out this morning on QSAM Biosciences, Inc. (OTC - QSAM) affirms our thesis, broadens reach, and enhances its valuation.

Undervalued RDE, Inc. (OTCQB - RSTN) owns the most identifiable brand in the restaurant-focused digital deals industry and stands to emerge as one of the greatest beneficiaries of the expected economic recovery this year.

Undervalued and underfollowed Infinite Group, Inc. (OTC - IMCI) is primed to enjoy huge gains this year on the heels of new cyber services and SaaS platform growth and the launch of an aggressive roll-up strategy.

QSAM Biosciences Inc. (OTCQB - QSAM) is built for multiple cancer therapy clinical trials for its novel bone cancer cells-killing therapy and we foresee a sale of the company in the cards as well.